FDA flags rare optic nerve damage risk in diabetes/weight drugs after trial review
Published 1 d ago2 sourcesEvidence: Reported
A new study indicates that discontinuing weight-loss injections in type 2 diabetes patients is associated with a doubled risk of heart attack or stroke. The finding is based on observational data and requires confirmation, but it has significant implications for treatment adherence and cardiovascular risk management.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 18 h ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported